Amicus Therapeutics (FOLD) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $829000.0.
- Amicus Therapeutics' Interest & Investment Income fell 2331.17% to $829000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 3111.97%. This contributed to the annual value of $5.4 million for FY2024, which is 2360.84% down from last year.
- Per Amicus Therapeutics' latest filing, its Interest & Investment Income stood at $829000.0 for Q3 2025, which was down 2331.17% from $843000.0 recorded in Q2 2025.
- Amicus Therapeutics' Interest & Investment Income's 5-year high stood at $2.2 million during Q1 2023, with a 5-year trough of $50000.0 in Q2 2021.
- For the 5-year period, Amicus Therapeutics' Interest & Investment Income averaged around $973789.5, with its median value being $843000.0 (2025).
- As far as peak fluctuations go, Amicus Therapeutics' Interest & Investment Income plummeted by 9421.97% in 2021, and later surged by 155338.35% in 2023.
- Quarter analysis of 5 years shows Amicus Therapeutics' Interest & Investment Income stood at $186000.0 in 2021, then surged by 960.22% to $2.0 million in 2022, then decreased by 15.26% to $1.7 million in 2023, then dropped by 15.26% to $1.4 million in 2024, then crashed by 41.45% to $829000.0 in 2025.
- Its Interest & Investment Income was $829000.0 in Q3 2025, compared to $843000.0 in Q2 2025 and $812000.0 in Q1 2025.